Skip to main content
Clinical Trials/NCT02951741
NCT02951741
Completed
Not Applicable

Relations Between Hematologic Variables and Postoperative Bleeding and Transfusion in Revision Total Hip Replacement Arthroplasty

Seoul National University Bundang Hospital1 site in 1 country62 target enrollmentApril 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Avascular Necrosis of Hip
Sponsor
Seoul National University Bundang Hospital
Enrollment
62
Locations
1
Primary Endpoint
Change of FIBTEM
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Revision total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables and postoperative bleeding volume.

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
February 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyo-Seok Na

Associate Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • revision total hip replacement

Exclusion Criteria

  • hematologic disease
  • anticoagulant medication
  • American Society of Anesthesiologists physical status 4 and 5

Outcomes

Primary Outcomes

Change of FIBTEM

Time Frame: 5 minutes before initiation of anesthesia and 5 minutes after finishing operation

FIBTEM: one of the measurements of the rotational thromboelastometry

Secondary Outcomes

  • volume of infused fluid during operation(Period from starting to finishing the operation (During operation, an expected average of 3 hours))
  • intraoperative urine output(Period from starting to finishing the operation (During operation, an expected average of 3 hours))
  • transfusion units(Period from starting to finishing the operation (During operation, an expected average of 3 hours) and postoperative first day)
  • activated partial prothrombin time(postoperative day 1)
  • postoperative bleeding volume(postoperative 72 hours)
  • fibrinogen concentration(postoperative day 1)
  • Hemoglobin(postoperative day 4)
  • Hematocrit(postoperative day 4)
  • Platelet count(postoperative day 4)
  • prothrombin time_international normalized ratio(postoperative day 1)

Study Sites (1)

Loading locations...

Similar Trials